Shenzhen-based company WE LINKING, a specialist in implantable brain computer interfaces (BCI), has reportedly raised tens of millions of renminbi in an angel financing round. The round was led by Gaorong Capital, with additional investments from Beijing Life Science Park Innovation Investment Fund, Qiji Investment, and existing investor CDH Investments.
WE LINKING’s Focus and Future Plans
WE LINKING is focused on brain machine smart fusion technology and aims to leverage core technologies of brain machine interfaces, such as physiological signal detection and peripheral nerve regulation, to develop wearable devices and related products in the fields of motor function rehabilitation and sleep over the next 2-3 years. The company’s strategic plan aligns with the growing interest in non-invasive and implantable BCI solutions for various medical and consumer applications.
Research and Development Priorities
The proceeds from the financing will be directed towards the research and development of WE LINKING’s fully implantable medical-grade brain computer interface system. This includes clinical research on implantable ultra-flexible high-density electrode arrays, clinical application verification of a thousand-channel medical-grade neural signal acquisition and processing system, finalization of a hundred-channel neuroelectronic chip, and verification of precise neural regulation technology for bidirectional brain computer interfaces. Additionally, the funds will support the wireless broadband communication verification of neural signals, a critical aspect of ensuring seamless data transmission in BCI applications.-Fineline Info & Tech
